The future of toxicology policies lies in the integration of new scientific advancements and technologies. This includes the use of in silico methods for predictive toxicology, high-throughput screening, and the application of big data analytics for risk assessment. As our understanding of toxicodynamics and toxicokinetics evolves, policies will continue to adapt to address complex issues such as cumulative exposures and endocrine disruptors.
